Fingerprint
Dive into the research topics of 'A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically